As of 2025-03-22, the Relative Valuation of Vaxart Inc (VXRT) is (3.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.52 USD, the upside of Vaxart Inc based on Relative Valuation is -739.3%.
The range of the Relative Valuation is (1.59) - (4.83) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.0x - 16.3x | 10.6x |
| Forward P/E multiples | 5.0x - 15.2x | 10.1x |
| Fair Price | (1.59) - (4.83) | (3.30) |
| Upside | -408.1% - -1036.6% | -739.3% |
| Date | P/E |
| 2025-03-17 | -1.76 |
| 2025-03-14 | -1.70 |
| 2025-03-13 | -1.63 |
| 2025-03-12 | -1.73 |
| 2025-03-11 | -1.46 |
| 2025-03-10 | -1.45 |
| 2025-03-07 | -1.48 |
| 2025-03-06 | -1.48 |
| 2025-03-05 | -1.48 |
| 2025-03-04 | -1.48 |
| 2025-03-03 | -1.48 |
| 2025-02-28 | -1.60 |
| 2025-02-27 | -1.55 |
| 2025-02-26 | -1.64 |
| 2025-02-25 | -1.56 |
| 2025-02-24 | -1.58 |
| 2025-02-21 | -2.24 |
| 2025-02-20 | -2.22 |
| 2025-02-19 | -2.28 |
| 2025-02-18 | -2.30 |
| 2025-02-14 | -2.35 |
| 2025-02-13 | -2.37 |
| 2025-02-12 | -2.28 |
| 2025-02-11 | -2.25 |
| 2025-02-10 | -2.17 |
| 2025-02-07 | -2.23 |
| 2025-02-06 | -2.32 |
| 2025-02-05 | -2.41 |
| 2025-02-04 | -2.25 |
| 2025-02-03 | -2.21 |
| 2025-01-31 | -2.14 |
| 2025-01-30 | -2.25 |
| 2025-01-29 | -2.28 |
| 2025-01-28 | -2.37 |
| 2025-01-27 | -2.29 |
| 2025-01-24 | -2.47 |
| 2025-01-23 | -2.42 |
| 2025-01-22 | -2.57 |
| 2025-01-21 | -2.40 |
| 2025-01-17 | -2.33 |
| 2025-01-16 | -2.33 |
| 2025-01-15 | -2.33 |
| 2025-01-14 | -2.30 |
| 2025-01-13 | -2.26 |
| 2025-01-10 | -2.48 |
| 2025-01-08 | -2.55 |
| 2025-01-07 | -2.76 |
| 2025-01-06 | -2.96 |
| 2025-01-03 | -2.63 |
| 2025-01-02 | -2.26 |